Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abeona Therapeutics (NQ: ABEO ) 3.910 -0.230 (-5.56%) Streaming Delayed Price Updated: 12:13 PM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Abeona Therapeutics < Previous 1 2 Next > Abeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL™ Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting March 16, 2023 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces Update on AAV Ophthalmology Program March 14, 2023 From Abeona Therapeutics Inc. Via GlobeNewswire Three Small-Cap Biotech Stocks to Consider Now December 12, 2022 This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 Via MarketBeat Abeona Therapeutics Reports Third Quarter 2022 Financial Results November 14, 2022 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces $35 Million Private Placement Financing November 03, 2022 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces Positive Topline Results with Both Co-Primary Endpoints Met in Pivotal Phase 3 VIITAL™ Study of EB-101 November 03, 2022 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces Database Lock for Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) October 19, 2022 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) October 04, 2022 Topline VIITAL™ study results expected within the next month From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Inc. (NASDAQ:ABEO) Investor Alert: Investigation over Potential Wrongdoing April 08, 2021 San Diego, CA -- (SBWIRE) -- 04/08/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Abeona Therapeutics Inc. Via SBWire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
